$CL·8-K

COLGATE PALMOLIVE CO · May 13, 4:02 PM ET

Compare

COLGATE PALMOLIVE CO 8-K

Research Summary

AI-generated summary

Updated

Colgate‑Palmolive Reports 2026 Annual Meeting Voting Results

What Happened
Colgate‑Palmolive Company (ticker: CL) filed an 8‑K on May 13, 2026 reporting the results of its Annual Meeting of Stockholders held May 8, 2026. All ten director nominees were elected, PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for 2026, the non‑binding advisory vote on executive compensation (say‑on‑pay) was approved, and two shareholder proposals—one on removing DEI from board candidate considerations and one to require an independent board chairman—were not approved.

Key Details

  • Director elections: All ten nominees were elected. Votes For ranged from 580,860,042 (John T. Cahill) to 630,748,353 (Christopher S. Boerner); Votes Against ranged from 5,728,013 to 55,593,274; abstentions and broker non‑votes were reported (broker non‑votes: 63,952,735).
  • Auditor ratification: PricewaterhouseCoopers LLP was ratified as the company’s independent registered public accounting firm for 2026 (For: 647,385,500; Against: 53,015,911; Abstentions: 1,204,733).
  • Say‑on‑pay: The non‑binding advisory vote on executive compensation passed (For: 591,185,556; Against: 43,039,011; Abstentions: 3,428,842).
  • Shareholder proposals failed: “Remove DEI from Board Candidate Considerations” (For: 14,002,273; Against: 618,251,142; Abstentions: 5,399,994) and “Independent Board Chairman” (For: 182,439,869; Against: 452,415,385; Abstentions: 2,798,155). Broker non‑votes on these items: 63,952,735.

Why It Matters
These outcomes confirm the board lineup and the auditor for 2026, maintaining the company’s current governance and oversight structure. Approval of the non‑binding say‑on‑pay indicates a majority of voting shareholders supported the company’s executive compensation approach. The decisive rejections of the two shareholder governance proposals signal that investors did not favor those changes at this meeting. Investors may view these results as continuity in leadership and governance policy for Colgate‑Palmolive through 2026.

Loading document...